Computer simulations help design molecules with potential as a cancer therapy

May 7, 2014
Biophysics: Stapling together cancer therapy
The key steps in designing stapled peptides: modeling of peptides when unbound (left), simulation of the peptide in complex with eIF4E to rationally design improved staples (center), and experimental determination of the structure of the complex to validate the method (right). Credit: p53 Laboratory

The synthesis of proteins by translation of RNA relies on a protein complex called eIF4F. As formation of this complex is frequently unregulated in cancers, the ability to restore its regulation could pave the way to develop new cancer therapies. A Singapore-based team headed by Christopher Brown and David Lane from the A*STAR p53 Laboratory and Dilraj Lama at the A*STAR Bioinformatics Institute have used computer modeling to design molecules that may be able to do just that.

Regulation of eIF4F involves disrupting an interaction between two proteins in the complex, eIF4E and eIF4G. Brown and colleagues set out to mimic this disruption with artificial peptides, or small protein fragments, that bind to eIF4E in the same way as eIF4G. To do this, they controlled the peptide structures using an approach called peptide stapling.

In the context of a whole protein, peptides usually form sections of localized structure, but when these peptides are removed from a protein they become linear and highly flexible, explains Brown. "A peptide staple is a chemical modification that can link two points of a peptide together and reintroduce the structure."

The research team designed different and ran computer simulations to reveal their structures, both when bound to eIF4E and when free in solution. They also synthesized the peptides and experimentally characterized their structures (see image).

Combining the information obtained by both experimentation and simulation showed where there was potential for improvement. "This meant we could design new stapled peptides, which could then be further characterized through experiments and also through computer simulations," says Brown. "The new designs altered individual amino acids. The aim of these alterations was to either optimize the peptide when bound to eIF4E or, when in solution, to make it look more like the bound structure."

Using the optimization process, the team produced two stapled peptides that interacted strongly with eIF4E. This required modification so that their structures would stay the same in solution as when bound to eIF4E.

"We developed a process to design highly potent inhibitors of an interaction relevant to disease," says Brown. "Our next step is to further understand how and why certain stapled peptides are biologically active whilst others are not."

Although these stapled peptides are not yet ready for use in treatment, Brown hopes this will change soon. "In the future, we envision developing the eIF4E stapled interacting into biologically active molecules and testing them in relevant disease models."

Explore further: Cancer biology: Targeting tumors with 'stapled' peptides

More information: Lama, D., Quah, S. T., Verma, C. S., Lakshminarayanan, R., Beuerman, R. W. et al. "Rational optimization of conformational effects induced by hydrocarbon staples in peptides and their binding interfaces." Scientific Reports 3, 3451 (2013). dx.doi.org/10.1038/srep03451

Related Stories

Cancer biology: Targeting tumors with 'stapled' peptides

July 17, 2013
(Phys.org) —Designer peptides containing chemically stabilized helices emerge as a potent way to activate anti-tumor proteins inside cells.

Novel stapled peptide nanoparticle combination prevents RSV infection, study finds

April 17, 2014
New therapies are needed to prevent and treat respiratory syncytial virus (RSV) – a potentially lethal respiratory infection that can severely affect infants, young children and the elderly.

Experimental 'stapled peptide' drug blocks key cancer molecule

August 24, 2012
(Medical Xpress)—US scientists have developed an artificial molecule called a 'stapled peptide' that can shut down the cancer-fuelling effects of a molecule called Wnt. 

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.